Limited coverage criteria – hydromorphone injection
Last updated on March 18, 2025
Return to Special Authority drug list
Generic name |
hydromorphone |
|---|---|
Strength & form |
50 mg/mL injection |
Special Authority criteria |
Approval period |
|---|---|
|
Relief of severe pain in patients who require subcutaneously, intravenously or intramuscularly administered opioids in doses or concentrations higher than those usually needed |
1 year |
Practitioner exemptions
- No practitioner exemptions.
Special notes
- Hydromorphone 10 mg/mL and 20 mg/mL are available as regular benefits on the PharmaCare formulary for the indication of severe pain only
- Hydromorphone 50 mg/mL is a benefit for the treatment of severe pain under Plans B and P